SUNLINDAC (Direct Rx)
Welcome to the PulseAid listing for the SUNLINDAC drug offered from Direct Rx. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Direct Rx |
NON-PROPRIETARY NAME: | SULINDAC |
SUBSTANCE NAME: | SULINDAC |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-01-01 |
END MARKETING DATE: | 0000-00-00 |
SUNLINDAC HUMAN PRESCRIPTION DRUG Details:
Item Description | SUNLINDAC from Direct Rx |
LABELER NAME: | Direct Rx |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2014-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61919-211_43ca706a-27e1-2f93-e054-00144ff88e88 |
PRODUCT NDC: | 61919-211 |
APPLICATION NUMBER: | ANDA072051 |
Other SULINDAC Pharmaceutical Manufacturers / Labelers: